Lymph node check before surgery for bile duct cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how well a special ultrasound-guided biopsy checks lymph nodes before surgery or liver transplant for bile duct cancer. The goal is to see if this method accurately shows whether the cancer has spread to nearby lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of bile duct cancer that your doctor thinks can be removed with surgery, or you have a certain type being prepared for a liver transplant.
- You are over 18 years old.
- You agree to take part by signing a consent form.
- You have not had treatment for bile duct cancer before.
- You have not had a liver cancer treated before.
- You do not have a bleeding problem that makes it unsafe to have an endoscopic ultrasound with biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy (gemcitabine and cisplatin) combined with immunotherapy (pembrolizumab) before and after surgery can improve outcomes compared to having surgery right away. It is for people with bile duct cancer that can be removed or is borderline removable.
This trial tests a new type of PET-CT scan (called FAPI) to see if it helps doctors better decide treatment for people with bile duct cancer that can be surgically removed. It may help avoid unnecessary surgery if the scan shows the cancer has spread.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
Hear when a new Hilar Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.